Patricia L Morris

Array ( [id] => 8410375 [patent_doc_number] => 08273772 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-25 [patent_title] => 'Heteroaryl compounds as P2Y1 receptor inhibitors' [patent_app_type] => utility [patent_app_number] => 12/619702 [patent_app_country] => US [patent_app_date] => 2009-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 64660 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12619702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6544063 [patent_doc_number] => 20100125094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-20 [patent_title] => 'PYRROLIDINYL MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS' [patent_app_type] => utility [patent_app_number] => 12/618934 [patent_app_country] => US [patent_app_date] => 2009-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10838 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20100125094.pdf [firstpage_image] =>[orig_patent_app_number] => 12618934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8932708 [patent_doc_number] => 08492408 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-23 [patent_title] => 'Benzimidazole derivatives and their use for modulating the GABAA receptor complex' [patent_app_type] => utility [patent_app_number] => 13/129066 [patent_app_country] => US [patent_app_date] => 2009-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7076 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13129066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9524348 [patent_doc_number] => 08748619 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-10 [patent_title] => 'Process for the resolution of omeprazole' [patent_app_type] => utility [patent_app_number] => 13/504224 [patent_app_country] => US [patent_app_date] => 2009-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5426 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13504224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6223151 [patent_doc_number] => 20100056571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'NOVEL PYRAZOLE COMPOUNDS AS TRANSFORMING GROWTH FACTOR (TGF) INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/617027 [patent_app_country] => US [patent_app_date] => 2009-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12165 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056571.pdf [firstpage_image] =>[orig_patent_app_number] => 12617027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8738508 [patent_doc_number] => 08410278 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-02 [patent_title] => 'Method for preparing a non-hydratable crystal form' [patent_app_type] => utility [patent_app_number] => 13/121218 [patent_app_country] => US [patent_app_date] => 2009-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5327 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13121218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6167316 [patent_doc_number] => 20110195930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'PYRIDINE DERIVATIVE OR ITS SALT, PESTICIDE CONTAINING IT AND PROCESS FOR ITS PRODUCTION' [patent_app_type] => utility [patent_app_number] => 13/125582 [patent_app_country] => US [patent_app_date] => 2009-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16464 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20110195930.pdf [firstpage_image] =>[orig_patent_app_number] => 13125582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9273618 [patent_doc_number] => 08637550 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-28 [patent_title] => 'Heteroaryl diamide compounds useful as MMP-13 inhibitors' [patent_app_type] => utility [patent_app_number] => 13/127256 [patent_app_country] => US [patent_app_date] => 2009-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21426 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13127256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8201173 [patent_doc_number] => 08188123 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-29 [patent_title] => '(Pyrrolidin-2-yl)phenyl derivatives' [patent_app_type] => utility [patent_app_number] => 12/611468 [patent_app_country] => US [patent_app_date] => 2009-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8312 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/188/08188123.pdf [firstpage_image] =>[orig_patent_app_number] => 12611468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6296808 [patent_doc_number] => 20100160635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'INDUSTRIAL PROCESS FOR PREPARATION OF CLOPIDOGREL HYDROGEN SULPHATE' [patent_app_type] => utility [patent_app_number] => 12/607714 [patent_app_country] => US [patent_app_date] => 2009-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8294 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20100160635.pdf [firstpage_image] =>[orig_patent_app_number] => 12607714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6321084 [patent_doc_number] => 20100113475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'PYRAZOLYLAMINOPYRIDINES AS INHIBITORS OF FAK' [patent_app_type] => utility [patent_app_number] => 12/606390 [patent_app_country] => US [patent_app_date] => 2009-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32919 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113475.pdf [firstpage_image] =>[orig_patent_app_number] => 12606390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6017231 [patent_doc_number] => 20110224441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => ' METHOD FOR THE PREPARATION OF DABIGATRAN AND ITS INTERMEDIATES' [patent_app_type] => utility [patent_app_number] => 13/124034 [patent_app_country] => US [patent_app_date] => 2009-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2112 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20110224441.pdf [firstpage_image] =>[orig_patent_app_number] => 13124034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6064245 [patent_doc_number] => 20110201591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'ISONICOTINAMIDE OREXIN RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/124568 [patent_app_country] => US [patent_app_date] => 2009-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18590 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20110201591.pdf [firstpage_image] =>[orig_patent_app_number] => 13124568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6478470 [patent_doc_number] => 20100041660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'NOVEL 2-PYRIDINECARBOXAMIDE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/604835 [patent_app_country] => US [patent_app_date] => 2009-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56045 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041660.pdf [firstpage_image] =>[orig_patent_app_number] => 12604835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10864173 [patent_doc_number] => 08889873 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-18 [patent_title] => 'Process for the preparation of enantiomerically enriched proton pump inhibitors' [patent_app_type] => utility [patent_app_number] => 13/124082 [patent_app_country] => US [patent_app_date] => 2009-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11745 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13124082 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9239416 [patent_doc_number] => 08604209 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Methods for preparing oxazolidinones and compositions containing them' [patent_app_type] => utility [patent_app_number] => 12/577089 [patent_app_country] => US [patent_app_date] => 2009-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7065 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12577089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7488483 [patent_doc_number] => 20110251390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'NICOTINE-BASED COMPOUNDS USEFUL FOR ASYMMETRIC SYNTHESIS' [patent_app_type] => utility [patent_app_number] => 13/122060 [patent_app_country] => US [patent_app_date] => 2009-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13359 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20110251390.pdf [firstpage_image] =>[orig_patent_app_number] => 13122060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6321533 [patent_doc_number] => 20100113527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'CRYSTALLINE FORMS OF DEXLANSOPRAZOLE' [patent_app_type] => utility [patent_app_number] => 12/571100 [patent_app_country] => US [patent_app_date] => 2009-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10602 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113527.pdf [firstpage_image] =>[orig_patent_app_number] => 12571100 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8982312 [patent_doc_number] => 08513427 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-20 [patent_title] => 'Compounds for producing substituted sulfoxides, process for producing the same and use thereof' [patent_app_type] => utility [patent_app_number] => 13/121387 [patent_app_country] => US [patent_app_date] => 2009-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5614 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13121387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6550285 [patent_doc_number] => 20100016606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'PREPARATION OF AMORPHOUS HYDROUS ESOMEPRAZOLE MAGNESIUM' [patent_app_type] => utility [patent_app_number] => 12/568301 [patent_app_country] => US [patent_app_date] => 2009-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6790 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016606.pdf [firstpage_image] =>[orig_patent_app_number] => 12568301 [rel_patent_id] =>[rel_patent_doc_number] =>)